These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37953189)

  • 1. Information provision and follow-up of French patients with implantable cardioverter-defibrillators: The APODEC survey.
    Halin A; Hamelin JL; Defaye P; Deharo JC; Fauchier L; Marijon E; Piot O; Boveda S
    Arch Cardiovasc Dis; 2023 Dec; 116(12):572-579. PubMed ID: 37953189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring.
    Galand V; Hwang E; Gandjbakhch E; Sebag F; Marijon E; Boveda S; Leclercq C; Defaye P; Rosier A; Martins RP
    Arch Cardiovasc Dis; 2021 May; 114(5):407-414. PubMed ID: 34088625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the patients' experiences of living with a subcutaneous implantable cardioverter defibrillator.
    Forman J; Baumbusch J; Jackson H; Lindenberg J; Shook A; Bashir J
    Eur J Cardiovasc Nurs; 2018 Dec; 17(8):698-706. PubMed ID: 29775072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
    Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
    J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.
    Araújo CS; Silva CLB; da Silva Menezes Júnior A; Barbosa VA; de Almeida Laranjeira T; Fernandes JF; Gonçalves LC; Silva AMC
    Curr Cardiol Rev; 2022; 18(3):e081221198647. PubMed ID: 34879809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients.
    Zangger G; Zwisler AD; Kikkenborg Berg S; Kristensen MS; Grønset CN; Uddin J; Pedersen SS; Oldridge NB; Thygesen LC
    Eur J Prev Cardiol; 2018 Jan; 25(2):142-149. PubMed ID: 28952795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with health-related quality of life among patients with implantable cardioverter defibrillator: identification of foci for nursing intervention.
    Wong FM; Sit JW; Wong EM; Choi KC
    J Adv Nurs; 2014 Dec; 70(12):2821-34. PubMed ID: 24754723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(7):1-199. PubMed ID: 30443279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.
    Meissner MD; Lehmann MH; Steinman RT; Mosteller RD; Akhtar M; Calkins H; Cannom DS; Epstein AE; Fogoros RN; Liem LB
    J Am Coll Cardiol; 1993 May; 21(6):1406-12. PubMed ID: 8473649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E
    Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial.
    Versteeg H; Timmermans I; Widdershoven J; Kimman GJ; Prevot S; Rauwolf T; Scholten MF; Zitron E; Mabo P; Denollet J; Pedersen SS; Meine M
    Europace; 2019 Sep; 21(9):1360-1368. PubMed ID: 31168604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an education and follow-up programme for implantable cardioverter defibrillator-implanted patients.
    Cinar FI; Tosun N; Kose S
    J Clin Nurs; 2013 Sep; 22(17-18):2474-86. PubMed ID: 23551749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey.
    Januszkiewicz Ł; Barra S; Providencia R; Conte G; de Asmundis C; Chun JKR; Farkowski MM; Guerra JM; Marijon E; Boveda S
    Europace; 2022 May; 24(5):860-867. PubMed ID: 35167672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.